MySheen

Production of Vaccine from transgenic Agaricus bisporus in the United States

Published: 2024-11-05 Author: mysheen
Last Updated: 2024/11/05, Researchers in the United States are planning to use genetically modified mushrooms to produce millions of doses of vaccines and other drugs within three months. Professor PeterRomaine from the University of Pennsylvania and his team have patented genetically modified Agaricus bisporus. The U.S. Department of Homeland Security Advanced projects Agency awarded Professor PeterRomaine $2.2 million as start-up funding for the project. Homeland Security officials say that if the research project goes well and succeeds, the entire project budget will reach $5.9 million. "I...

Researchers in the United States are planning to use genetically modified mushrooms to produce millions of doses of vaccines and other drugs within three months. Professor PeterRomaine from the University of Pennsylvania and his team have patented genetically modified Agaricus bisporus.

The U.S. Department of Homeland Security Advanced projects Agency awarded Professor PeterRomaine $2.2 million as start-up funding for the project. Homeland Security officials say that if the research project goes well and succeeds, the entire project budget will reach $5.9 million.

"our medium-term goal is to achieve efficient expression of biopharmaceuticals in mushrooms, and then extract and purify these drugs from mushrooms in an efficient and economical way." Romaine said.

Vaccines or drugs will eventually be extracted from mushrooms and transformed into forms that can be used by humans. In the third year after the launch of the project, the researchers hope to demonstrate its large-scale commercial production capacity to produce millions of vaccines or other drugs on a mushroom platform over a period of 12 weeks.

 
0